Immunogenicity of a Fractional Dose of mRNA BNT162b2 COVID-19 Vaccine for Primary Series and Booster Vaccination among Healthy Adolescents

Primary series vaccination with BNT162b2 followed by a booster 5 months later has been recommended for healthy adolescents. We aimed to describe the immunogenicity in a fractional dose of BNT162b2. Adolescents aged 12–18 years were randomized into six arms for primary series administration: 3wPZ30/3...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Thanyawee Puthanakit, Napaporn Chantasrisawad, Kirana Yoohat, Rapisa Nantanee, Jiratchaya Sophonphan, Thutsanun Meepuksom, Pimpayao Sodsai, Supranee Phanthanawiboon, Watsamon Jantarabenjakul, Nattiya Hirankarn, Pope Kosalaraksa
Formato:	Artigo
Idioma:	Inglês
Publicado em:	MDPI AG 2022-09-01
coleção:	Vaccines
Assuntos:	SARS-CoV-2 vaccine adolescents neutralizing antibody titer anti-SARS-CoV-2 fractional dose BNT162b2
Acesso em linha:	https://www.mdpi.com/2076-393X/10/10/1646
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!